Literature DB >> 8607104

Variation of phylloquinone (vitamin K1) concentrations in hemodialysis patients.

M Kohlmeier1, J Saupe, H J Drossel, M J Shearer.   

Abstract

Intra- and interindividual variation of phylloquinone (vitamin K1) concentrations was investigated by repeat analysis of serum from 28 hemodialysis patients with different apolipoprotein E genotypes. Phylloquinone concentrations ranged from 0.1 to 9.0 nM, with a mean of 1.08 nM (standard deviation 1.90 nM). Most of the variation in serum phylloquinone concentrations was due to differences between patients; the ratio of intra- to interindividual variation was 0.17. Serum triglyceride concentrations and apoE genotype together accounted for 64% of interindividual variation; in contrast, only 6% of intraindividual variation could be attributed to differences in triglyceride concentrations. The small residual variance implies that different phylloquinone consumption levels contributed relatively little to the variation of serum concentrations ( < 36% of interindividual variance). The results suggest that individual disposition is a more important determinant of serum phylloquinone concentrations than dietary phylloquinone intake.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8607104

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  7 in total

1.  Apolipoprotein E (APOE) and warfarin dosing in an Italian population.

Authors:  Hugo Kohnke; Maria Gabriella Scordo; Vittorio Pengo; Roberto Padrini; Mia Wadelius
Journal:  Eur J Clin Pharmacol       Date:  2005-08-26       Impact factor: 2.953

Review 2.  Vitamin K, bone fractures, and vascular calcifications in chronic kidney disease: an important but poorly studied relationship.

Authors:  M Fusaro; G Crepaldi; S Maggi; F Galli; A D'Angelo; L Calò; S Giannini; D Miozzo; M Gallieni
Journal:  J Endocrinol Invest       Date:  2010-11-16       Impact factor: 4.256

3.  Relationship between diet and anticoagulant response to warfarin: a factor analysis.

Authors:  Silvia Maria Custódio das Dôres; Sarah L Booth; Ligia Araújo Martini; Ligia Aújo Martini; Victor Hugo de Carvalho Gouvêa; Carlos Roberto Padovani; Francisco Humberto de Abreu Maffei; Alvaro Oscar Campana; Sérgio Alberto Rupp de Paiva
Journal:  Eur J Nutr       Date:  2007-03-13       Impact factor: 5.614

4.  The circulating inactive form of matrix gla protein is a surrogate marker for vascular calcification in chronic kidney disease: a preliminary report.

Authors:  Leon J Schurgers; Daniela V Barreto; Fellype C Barreto; Sophie Liabeuf; Cédric Renard; Elke J Magdeleyns; Cees Vermeer; Gabriel Choukroun; Ziad A Massy
Journal:  Clin J Am Soc Nephrol       Date:  2010-02-04       Impact factor: 8.237

5.  Biological Systems of Vitamin K: A Plasma Nutriproteomics Study of Subclinical Vitamin K Deficiency in 500 Nepalese Children.

Authors:  Sun Eun Lee; Kerry J Schulze; Robert N Cole; Lee S F Wu; James D Yager; John Groopman; Parul Christian; Keith P West
Journal:  OMICS       Date:  2016-02-25

6.  VKORC1-dependent pharmacokinetics of intravenous and oral phylloquinone (vitamin K1) mixed micelles formulation.

Authors:  Milka Marinova; Dieter Lütjohann; Olof Breuer; Heike Kölsch; Philipp Westhofen; Matthias Watzka; Martin Mengel; Birgit Stoffel-Wagner; Gunther Hartmann; Christoph Coch; Johannes Oldenburg
Journal:  Eur J Clin Pharmacol       Date:  2012-08-05       Impact factor: 2.953

Review 7.  Vitamin K status in chronic kidney disease.

Authors:  Kristin M McCabe; Michael A Adams; Rachel M Holden
Journal:  Nutrients       Date:  2013-11-07       Impact factor: 5.717

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.